Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Gilead Sciences Identifier:
First received: April 22, 2014
Last updated: February 29, 2016
Last verified: February 2016